Insights from 2023 ESMO Asia Annual Meeting
Final Analysis of a Ph2 Study of Neoadjuvant S-1 + Oxaliplatin in Older Patients With Locally Advanced Gastric Cancer
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Eiji Oki
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Eiji Oki
Comments 0
Login to view comments.
Click here to Login